Conversations in Hematology/Oncology: Leukemic Transformation of Myelodysplastic Syndromes: Identification, Evaluation and Management Issues

Search Clear

Certified AMA/ANCC/ACPE Activity

These certified AMA/ANCC/ACPE activities feature a discussion among three experts that will review the current and emerging treatment landscape of high-risk myelodysplastic syndromes (MDS). The program includes two activities that will feature the faculty discussing recent updates in the standard of care for high-risk MDS and what is on the horizon for high-risk MDS.

Review one or all activities of interest. Claim AMA, ANCC, or ACPE credit/contact hour(s) per activity after completion of each brief Post-Test/Evaluation.

/cmetest.aspx?testid=

Supported by independent educational grants from Genentech, Novartis, Taiho and Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited

Mini Module

7229

ConversationsInMDS_WebBanner(1150).gif

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Hematology-Oncology

CookieConsent

Change Settings

From:
To:
Subject:	I'd like to recommend this activity on www.PracticePointCME.com
Message:

CookieConsent

PRACTICE POINT CME

PRACTICE POINT COMMUNICATIONS

THERAPEUTIC AREAS

RESOURCES